- Home
- CCJ vs ALC Comparison
CCJ vs ALC Comparison
Compare CCJ & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCJ
- ALC
- Stock Information
- Founded
- CCJ 1987
- ALC 1945
- Country
- CCJ Canada
- ALC Switzerland
- Employees
- CCJ N/A
- ALC N/A
- Industry
- CCJ Other Metals and Minerals
- ALC Ophthalmic Goods
- Sector
- CCJ Basic Materials
- ALC Health Care
- Exchange
- CCJ Nasdaq
- ALC Nasdaq
- Market Cap
- CCJ 34.0B
- ALC 40.2B
- IPO Year
- CCJ N/A
- ALC N/A
- Fundamental
- Price
- CCJ $106.67
- ALC $73.60
- Analyst Decision
- CCJ Strong Buy
- ALC Buy
- Analyst Count
- CCJ 4
- ALC 11
- Target Price
- CCJ $99.07
- ALC $91.41
- AVG Volume (30 Days)
- CCJ 6.2M
- ALC 2.2M
- Earning Date
- CCJ 11-05-2025
- ALC 11-11-2025
- Dividend Yield
- CCJ 0.11%
- ALC 0.29%
- EPS Growth
- CCJ 106.70
- ALC N/A
- EPS
- CCJ 0.89
- ALC 2.16
- Revenue
- CCJ $2,617,729,824.00
- ALC $10,025,000,000.00
- Revenue This Year
- CCJ $11.04
- ALC $5.94
- Revenue Next Year
- CCJ $3.96
- ALC $7.71
- P/E Ratio
- CCJ $119.32
- ALC $34.39
- Revenue Growth
- CCJ 34.69
- ALC 4.04
- 52 Week Low
- CCJ $35.00
- ALC $71.55
- 52 Week High
- CCJ $110.16
- ALC $99.20
- Technical
- Relative Strength Index (RSI)
- CCJ 74.04
- ALC 39.58
- Support Level
- CCJ $84.29
- ALC $71.55
- Resistance Level
- CCJ $110.16
- ALC $77.01
- Average True Range (ATR)
- CCJ 5.39
- ALC 1.17
- MACD
- CCJ 1.51
- ALC 0.20
- Stochastic Oscillator
- CCJ 88.24
- ALC 37.55
About CCJ Cameco Corporation
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. It has three reportable segments, Uranium, Fuel Services, and Westinghouse. It derives maximum revenue from the Westinghouse Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre, and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia, and the United States.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.